Trichotillomania and its clinical relationship to depression and anxiety

Carregando...
Imagem de Miniatura
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Autores
GRANT, Jon E.
REDDEN, Sarah A.
ODLAUG, Brian L.
CURLEY, Erin E.
KEUTHEN, Nancy J.
Citação
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, v.21, n.4, p.302-306, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: Trichotillomania (TTM) is associated with high rates of co-occurring depression and anxiety disorders. What the co-occurrence of TTM, depression or anxiety disorders means clinically and cognitively, however, has garnered little research attention.Methods: About 530 adults with TTM were examined on a variety of clinical measures including symptom severity, psychosocial measures of functioning, psychiatric comorbidity and neurocognitive testing assessing motor inhibition and cognitive flexibility. Clinical features and cognitive functioning were compared between TTM patients with current comorbid major depressive disorder (MDD), a current anxiety disorder, both MDD and an anxiety disorder, or neither.Results: Of 530 participants, 58 (10.3%) had MDD only, 97 (18.3%) had an anxiety disorder only, 58 (10.3%) had both MDD and an anxiety disorder, and 317 (59.8%) had neither. For almost all clinical measures, those with MDD only reported worse symptoms than those with an anxiety disorder only, and the combination of MDD and an anxiety disorder reported the worst level of symptom severity.Conclusions: These results suggest that adults with TTM and co-occurring MDD and anxiety disorders exhibit unique clinical differences. The clinical differences may also have treatment implications.
Palavras-chave
Trichotillomania, depression, anxiety, comorbidity, cognition
Referências
  1. American Psychiatric Association, 2013, DIAGN STAT MAN MENT
  2. Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010
  3. Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282
  4. CHRISTENSON GA, 1991, AM J PSYCHIAT, V148, P365
  5. Christenson GA, 1999, TRICHOTILLOMANIA, P1
  6. Diefenbach GJ, 2005, BEHAV RES THER, V43, P869, DOI 10.1016/j.brat.2004.06.010
  7. Duke DC, 2010, CLIN PSYCHOL REV, V30, P181, DOI 10.1016/j.cpr.2009.10.008
  8. First MB, 1995, STRUCTURED CLIN INTE
  9. Frisch M. B., 1992, PSYCHOL ASSESSMENT, V4, P92, DOI 10.1037/1040-3590.4.1.92
  10. Grant JE, 2017, COMPR PSYCHIAT, V72, P1, DOI 10.1016/j.comppsych.2016.09.005
  11. Grant JE, 2016, AM J PSYCHIAT, V173, P868, DOI 10.1176/appi.ajp.2016.15111432
  12. Grant JE, 2011, J PSYCHIATR RES, V45, P1634, DOI 10.1016/j.jpsychires.2011.07.012
  13. Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298
  14. Gupta MA, 2013, CLIN DERMATOL, V31, P110, DOI 10.1016/j.clindermatol.2011.11.015
  15. Houghton DC, 2016, PSYCHIAT RES, V239, P12, DOI 10.1016/j.psychres.2016.02.063
  16. Keuthen NJ, 2007, J PSYCHOSOM RES, V62, P707, DOI 10.1016/j.jpsychores.2006.12.003
  17. Keuthen NJ, 2014, AM J MED GENET B, V165, P167, DOI 10.1002/ajmg.b.32218
  18. KEUTHEN NJ, 1995, PSYCHOTHER PSYCHOSOM, V64, P141
  19. Lochner C, 2004, COMPR PSYCHIAT, V45, P384, DOI 10.1016/j.comppsych.2004.03.010
  20. Mansueto CS., 1991, OCD NEWSLETTER, V5, P10
  21. Neal-Barnett A, 2011, CNS NEUROSCI THER, V17, P207, DOI 10.1111/j.1755-5949.2010.00138.x
  22. Odlaug BL, 2014, J PSYCHIATR RES, V59, P167, DOI 10.1016/j.jpsychires.2014.08.010
  23. OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E
  24. Penzel F., 2003, HAIR PULLING PROBLEM
  25. Sheehan D. V., 1983, ANXIETY DIS
  26. Stein DJ, 2006, CNS SPECTRUMS, V11, P824
  27. SWEDO SE, 1989, NEW ENGL J MED, V321, P497, DOI 10.1056/NEJM198908243210803
  28. U. S. Department of Health & Human Services, 2012, GUID REG METH DEID P
  29. Woods DW, 2006, J CLIN PSYCHIAT, V67, P1877